These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31112525)

  • 1. Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity.
    Xiao Y; Muhuri M; Li S; Qin W; Xu G; Luo L; Li J; Letizia AJ; Wang SK; Chan YK; Wang C; Fuchs SP; Wang D; Su Q; Nahid MA; Church GM; Farzan M; Yang L; Wei Y; Desrosiers RC; Mueller C; Tai PW; Gao G
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31112525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction.
    Muhuri M; Zhan W; Maeda Y; Li J; Lotun A; Chen J; Sylvia K; Dasgupta I; Arjomandnejad M; Nixon T; Keeler AM; Manokaran S; He R; Su Q; Tai PWL; Gao G
    Front Immunol; 2021; 12():674242. PubMed ID: 33995418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene delivery.
    Majowicz A; Maczuga P; Kwikkers KL; van der Marel S; van Logtenstein R; Petry H; van Deventer SJ; Konstantinova P; Ferreira V
    J Gene Med; 2013; 15(6-7):219-32. PubMed ID: 23658149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration.
    Brockstedt DG; Podsakoff GM; Fong L; Kurtzman G; Mueller-Ruchholtz W; Engleman EG
    Clin Immunol; 1999 Jul; 92(1):67-75. PubMed ID: 10413654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged gene expression in muscle is achieved without active immune tolerance using microrRNA 142.3p-regulated rAAV gene transfer.
    Boisgerault F; Gross DA; Ferrand M; Poupiot J; Darocha S; Richard I; Galy A
    Hum Gene Ther; 2013 Apr; 24(4):393-405. PubMed ID: 23427817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic transgene immunogenicity gears CD8(+) T-cell priming after rAAV-mediated muscle gene transfer.
    Carpentier M; Lorain S; Chappert P; Lalfer M; Hardet R; Urbain D; Peccate C; Adriouch S; Garcia L; Davoust J; Gross DA
    Mol Ther; 2015 Apr; 23(4):697-706. PubMed ID: 25492560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic protein delivery by muscle-gene transfer is limited by a local immune response.
    Wang L; Dobrzynski E; Schlachterman A; Cao O; Herzog RW
    Blood; 2005 Jun; 105(11):4226-34. PubMed ID: 15713796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer.
    Ferrand M; Galy A; Boisgerault F
    Gene Ther; 2014 Sep; 21(9):828-39. PubMed ID: 25030611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct immune responses to transgene products from rAAV1 and rAAV8 vectors.
    Lu Y; Song S
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17158-62. PubMed ID: 19805176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors.
    Sarukhan A; Soudais C; Danos O; Jooss K
    J Gene Med; 2001; 3(3):260-70. PubMed ID: 11437331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.
    Villegas-Mendez A; Garin MI; Pineda-Molina E; Veratti E; Bueren JA; Fender P; Lenormand JL
    Mol Ther; 2010 May; 18(5):1046-53. PubMed ID: 20179681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
    Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
    J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.
    Zhang Y; Chirmule N; Gao Gp; Wilson J
    J Virol; 2000 Sep; 74(17):8003-10. PubMed ID: 10933709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
    Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL
    Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction.
    Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O
    Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.
    Velazquez VM; Bowen DG; Walker CM
    Blood; 2009 Jan; 113(3):538-45. PubMed ID: 18566327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant activities of CTAB-modified Polygonatum sibiricum polysaccharide cubosomes on immune responses to ovalbumin in mice.
    Liu Z; Ni H; Yu L; Xu S; Bo R; Qiu T; Gu P; Zhu T; He J; Wusiman A; Zhu S; Liu J; Hu Y; Wang D
    Int J Biol Macromol; 2020 Apr; 148():793-801. PubMed ID: 31972196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual muscle-liver transduction imposes immune tolerance for muscle transgene engraftment despite preexisting immunity.
    Bartolo L; Li Chung Tong S; Chappert P; Urbain D; Collaud F; Colella P; Richard I; Ronzitti G; Demengeot J; Gross DA; Mingozzi F; Davoust J
    JCI Insight; 2019 Jun; 4(11):. PubMed ID: 31167976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene Transfer.
    Brimble MA; Morton CL; Winston SM; Reeves IL; Spence Y; Cheng PH; Zhou J; Nathwani AC; Thomas PG; Souquette A; Davidoff AM
    Hum Gene Ther; 2024 Jul; 35(13-14):477-489. PubMed ID: 38420654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.